New treatment options include: extension of the length of proton pump inhibitor-based triple therapies, sequential therapy, quadruple therapy, levofloxacin-based triple or quadruple therapy.

A literature search was conducted to evaluate the pharmacokinetic and pharmacodynamic profile of the respiratory fluoroquinolones (gemifloxacin, levofloxacin and moxifloxacin) and their efficacy ...

These include levofloxacin (Levaquin; Johnson & Johnson), moxifloxacin (Avelox; Bayer/Merck) and linezolid (Zyvox; Pfizer), which are expected to lose patent protection in 2011, 2014 and 2016 ...

Photoablation was performed using the WaveLight EX500 excimer laser (Alcon Laboratories, Inc, Fort Worth, Texas). Postoperative treatment included topical preservative-free dexamethasone and ...

Developed by the TB Alliance, pretomanid is part of two shorter, all-oral treatment regimens recommended by the World Health Organization for treating MDR-TB—BPaL (bedaquiline, pretomanid, and ...

Anthony Garcia-Prats, one of the study authors and an associate professor at the University of Wisconsin in Madison, said scientists have made strides in developing new treatments for drug ...